AGP Executive Report
Last update: 3 hours agoLegal Cannabis: Massachusetts voters decisively rejected a measure to end recreational sales and home cultivation, with 76% voting against repeal as results came in. Industry Moves: Organigram agreed to acquire Aurora Cannabis for about C$561 million, topping Curaleaf’s rival bid and promising a stronger foothold in Canada, Europe and Australia. Medical Access: The DEA has begun registering more than 900 state-licensed medical cannabis dispensaries under the new federal framework; Jushi says it has received registrations for some of its operations. Health Research: A national U.S. study found cannabis was involved in most substance-related emergency visits among adolescents and young adults, while alcohol predominated among older adults. CBD Medicine: Australia’s Avecho has restarted recruitment for the final cohort of its pivotal CBD insomnia trial, which it hopes will support a pharmacy-available medicine.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
